Russian Health Ministry registered nasal vaccine against COVID-19
The Russian Health Ministry has registered a drug developed by Generium for the prevention of coronavirus infection in the form of a nasal spray called Salnavak – as reported by TASS, referring to the information of the state register of medicines
Salnavak is a combined vector vaccine, the indication for use is the prevention of a new coronavirus infection in people aged 18-60 years. Vaccination should be carried out in two stages with an interval of three weeks, according to the instructions for the drug.
Generium is a Russian innovative biotechnology company, which includes a research institute, a clinical research management centre and high-tech production. The company specialises in the development and production of medicines, vaccines, and diagnostic systems, being also one of the creators of the Sputnik V coronavirus vaccine.